Ads
-
Related paper
- METFORMIN REDUCES TSH IN HYPOTHYROID TYPE 2 DIABETIC PATIENTS
- Comparative evaluation of effects of combined oral anti-diabetic drugs (sulfonylurea plus pioglitazone and sulfonylurea plus metformin) over lipid parameters in type 2 diabetic patients
- CLINICAL AND BIOCHEMIICAL MANIFESTATIONS OF VITAMIN B12 DEFICIENCY IN TYPE 2 DIABETIC PATIENTS TREATED WITH METFORMIN- A COMPARATIVE STUDY
- Improvement in lipid profile of the patients with saxagliptin as add on therapy to metformin in patients of type 2 DM who were previously on metformin alone with uncontrolled diabetes
- Evaluate the Efficacy of Metformin and Glimepiride with Metformin in Patients with Type II Diabetes Mellitus
- EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS
- EFFECT OF METFORMIN ON WEIGHT REDUCTION AMONG DIABETIC AND NON-DIABETIC OBESE PATIENTS
- The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus
- Improvement in lipid profile of the patients with saxagliptin as add on therapy in patients of uncontrolled type 2 DM who were on metformin alone
- Evaluation of Growth Differentiation Factor-15 in Non-Diabetic Hypothyroid Patients with Normal Insulin Sensitivity and Maintained on Oral Thyroxin Therapy